Croatia vs Latvia: HICP - Tea, mate and other plant-derived products for infusion (ND)
Croatia
1.72
in 2026
Latvia
1.88
in 2026
Croatia rank
5th
Latvia rank
4th
HICP - Tea, mate and other plant-derived products for infusion (ND) over time
- Croatia
- Latvia
How they compare
Latvia currently reports 1.88 against 1.72 in Croatia, a difference of 0.16.
That makes Latvia's figure about 1.1 times Croatia's.
The two have swapped places 4 times across 29 shared years of data; in 1998 it was Latvia ahead.
Croatia ranks 5th and Latvia ranks 4th of 27 countries.
Across the 4 decades both report, Croatia averaged higher in 1 and Latvia in 3.
Head to head by decade
| Decade | Croatia | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1.41 | 2.52 | 1.12 | Latvia |
| 2000s | 1.26 | 2.28 | 1.02 | Latvia |
| 2010s | 2.32 | 1.78 | 0.533 | Croatia |
| 2020s | 1.84 | 2.31 | 0.4657 | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hicp - tea, mate and other plant-derived products for infusion (nd), Croatia or Latvia?
- Latvia, at 1.88 against 1.72 in Croatia as of 2026.
- What is the difference in hicp - tea, mate and other plant-derived products for infusion (nd) between Croatia and Latvia?
- 0.16, with Latvia ahead.
- How many years of comparable data are there for Croatia and Latvia?
- 29 years are reported by both, from 1998 to 2026.
- How do Croatia and Latvia rank globally for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Croatia ranks 5th and Latvia ranks 4th of 27 countries.
- Where does this data come from?
- European Central Bank, published as HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid refreshes it automatically from the source and publishes the full history for both places.